After an intense ECCMID in Madrid, surrounded by the world top initiatives in the topic of infectious diseases, we are more and more confident about our approach towards combating difficult-to-treat bacteria. We thank the organization, speakers and attendances for another year of this great global congress in infectious diseases, infection control and clinical microbiology. If […]
We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). The project MDR-Phage brings together the expertise and resources from Synovo GmbH, Qualizyme Diagnostics, the University of Twente, and the University of Amsterdam. Within the project, we will test our anti-microbial library of compounds […]
Thanks to those who believe in us and let us participate in the development of their products by providing pharmacology services. We have just delivered the results from the pharmacology study service number 1000! THANK YOU
We expand business to ophthalmology Tübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic decision to extend its service portfolio on ophthalmic indications. Read more Synovo wird Anbieter für Dienstleistungen und Lösungen für Forschung und Entwicklung in der Augenheilkunde Tübingen, Februar 2014. Synovo, Spezialist für Identifikation […]